🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
252.73
-3.23 (-1.26%)
Nov 20, 2026, 4:00 PM EST - Market closed

Ascendis Pharma Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Net Income
876.72-228.03-378.08-481.45-583.19-383.58
Depreciation & Amortization
17.7717.2117.2518.4317.5114.95
Other Amortization
0.490.490.470.480.440.45
Loss (Gain) From Sale of Assets
0.02--0.090.010.02-
Asset Writedown & Restructuring Costs
-2.235.28-7.83--
Loss (Gain) on Equity Investments
11.96-16.3120.0618.417.7-12.04
Stock-Based Compensation
121.07116.1795.5166.6664.1866.83
Other Operating Activities
-545.1588.1345.852.070.11-56.53
Change in Accounts Receivable
-88.9115.59-118.61-32.77-11.53-6.66
Change in Inventory
-29.32-5.92-86.68-78.26-55.27-75.41
Change in Accounts Payable
59.12-10.3726.973.5545.9439.19
Change in Unearned Revenue
-0.960.13-1.2-7.088.655.2
Change in Other Net Operating Assets
115.5871.5372.3614.77-0.26-10.05
Operating Cash Flow
536.1553.9-306.2-467.36-495.7-417.65
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Capital Expenditures
-17.1-8.49-1.43-2.44-14.49-23.7
Sale of Property, Plant & Equipment
--0.950.05--
Sale (Purchase) of Intangibles
------0.53
Investment in Securities
--7.35288.8766.69-86.35
Other Investing Activities
----9.54-
Investing Cash Flow
-15.1-8.496.88286.4761.73-110.58

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Long-Term Debt Issued
--134.16136.26503.28-
Long-Term Debt Repaid
--21.96-11.37-10.44-6.36-6.43
Lease Payments
------6.43
Net Debt Issued (Repaid)
-32.58-21.96122.79125.82496.93-6.43
Issuance of Common Stock
88.4287.08340.4310.295.15379.42
Repurchase of Common Stock
-168.62-28.79--1.81-105.31-21.61
Other Financing Activities
-0.13--19.29---
Financing Cash Flow
-112.9136.33443.93134.29396.77351.39

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Foreign Exchange Rate Adjustments
17.13-25.2422.77-6.0135.6938.59
Net Cash Flow
425.2756.5167.38-52.6-1.5-138.25

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Free Cash Flow
519.0545.41-307.62-469.8-510.19-441.35
Free Cash Flow Growth
------
Free Cash Flow Margin
43.15%6.31%-84.60%-176.14%-996.97%-5674.38%
Free Cash Flow Per Share
7.940.75-5.31-8.35-9.10-8.06
Levered Free Cash Flow
140.77164.71-200.32-332.95-156.42-281.9
Unlevered Free Cash Flow
185.69215.12-159.38-305.41-137.24-279.45
Free Cash Flow After Leases
519.0545.41-307.62-469.8-510.19-447.78

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash Interest Paid
34.722.9415.2115.679.291.84
Cash Income Tax Paid
16.686.685.514.470-0.15
Change in Working Capital
55.5170.96-107.16-99.79-12.47-47.72
SEC Filings: 10-K · 10-Q